BioCryst Pharmaceuticals Inc
Closed
SectorHealthcare
10.74 -3.33
Overview
Share price change
24h
Min
10.67
Max
11.19
Income | -1.1B -722M |
|---|---|
Sales | -250M 156M |
P/E Sector Avg | 7.603 60.549 |
EPS | 0.14 |
Profit margin | -461.478 |
Employees | 435 |
EBITDA | -966M -700M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +118.63% upside |
Next Earnings | 3 sie 2026 |
|---|
Market Cap | 239M 2.6B |
|---|---|
Previous open | 14.07 |
Previous close | 10.74 |
News Sentiment
By Acuity
59%
41%
291 / 342 Ranking in Healthcare
BioCryst Pharmaceuticals Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
BioCryst Pharmaceuticals Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 24.29 USD 118.63%
High 32 USD
Low 14 USD
Based on 8 Wall Street analysts offering 12 month price targets forBioCryst Pharmaceuticals Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$